World's biggest drugmaker halts trial after results show drug caused an increase in deaths, heart problems.

On Saturday, Pfizer and the Food and Drug Administration announced that the drug company would halt a clinical trial of torcetrapib due to an increased rate of death and heart problems in patients who took it.

Just two days earlier, Pfizer's new CEO Jeffrey Kindler had told hundreds of investors and analysts at a research meeting that the drugmaker could seek approval for the medicine as early as next year if clinical data supported it.

For the complete article Click Here

For more information about CBI’s Cardiac Safety Summit Click Here

Source: CNN